Aristides Capital LLC Trinity Biotech PLC Transaction History

Aristides Capital LLC

  • $219 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
SELL
$0.38 - $0.7 $51,018 - $93,982
-134,260 Reduced 82.71%
28,057 $12,000
Q1 2023

May 12, 2023
SELL
$0.87 - $1.18 $49,775 - $67,511
-57,213 Reduced 26.06%
162,317 $152,000
Q4 2022

Feb 14, 2023
SELL
$0.98 - $6.15 $11,739 - $73,670
-11,979 Reduced 5.17%
219,530 $217,000
Q3 2022

Nov 15, 2022
SELL
$1.09 - $5.45 $9,995 - $49,976
-9,170 Reduced 3.81%
231,509 $248,000
Q2 2022

Aug 15, 2022
BUY
$0.96 - $1.44 $231,051 - $346,577
240,679 New
240,679 $295,000

Others Institutions Holding TRIB

# of Institutions
1
Shares Held
30.2K
Call Options Held
0
Put Options Held
0
View Full List

About TRINITY BIOTECH PLC

TRIB Quotes by TradingView
  • Ticker TRIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 38,107,600
  • Market Cap $42.7M
  • Description
  • Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious dis...
More about TRIB
Track This Portfolio

Track Aristides Capital LLC Portfolio

Follow Aristides Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristides Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristides Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email